We offer a diverse selection of FFPE, fresh and frozen tissue, blood, and biofluid samples. Sourced from traceable and controlled origins, these samples ensure exceptional integrity and reliability for both standard and specialized research, from molecular studies to clinical applications.
Primary Cell Lines & Assays
Our extensive repository includes tumor and normal cell lines, which can be complemented by a variety of cell-based assays and characterization services. Each line undergoes rigorous testing to ensure reproducibility and consistency, supporting cutting-edge research in molecular biology, cancer, and drug discovery.
3D Tumor Models & Drug Screening
Our 3D organoids and spheroids, derived from human tumors, closely replicate the architecture and microenvironment of original tissues. Coupled with robust characterization services, these models provide a reliable, reproducible platform for preclinical drug testing and development.
Customizable Models & Project Design
Our expert team provides comprehensive consulting services, offering scientific guidance on assay design, project planning, and navigating legal and ethical considerations to ensure successful outcomes using our tailored tumor models customized to reflect specific cancer types, patient genetics, and drug targets.
“DRL is committed to procuring high quality human specimens in a timely manner. Their scientists are engaged and proactive at addressing the needs of their clients. We are glad we entrusted DRL with helping us advance our target validation projects and will continue to use their professional services in the future.”
Alexander Adler
Principal Scientist @ Regeneron Pharmaceuticals, Inc.
"We prefer to work with DRL for our sample acquisition needs as they provide us with high quality materials in a timely manner. They are agile and able to adapt to our varied needs across projects and requests for different levels of documentation. They respond incredibly quickly and thoroughly to any queries. They complete their collections within projected time frames. Unfortunately for the space as a whole, these observations are in contrast to most vendors. In summary, they are a pleasure to work with and have become my preferred vendor."
John M. Lyle, PhD
VP Assay Development R&D @ Personalis
Contract research organization, which provides solutions for pharma and diagnostics companies, including consulting, cancer models development, and various assays for drug development.
